ATP3 Women
Loading...
References
- MD Paul M Ridker. Inflammation, Cholesterol, Lipoprotein(a) and 30-Year Cardiovascular Outcomes in Women. The New England journal of medicine, 2024
- M. Kavousi. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.. JAMA, 2014
- E. Michos. How accurate are 3 risk prediction models in US women?. Circulation, 2012
- D. Lloyd‐Jones. Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease. Annals of Internal Medicine, 2006
- Scott M. Grundy. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
- A. Gotto. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?. Circulation, 2002